Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
This trial will evaluate the clinical significance of the PRO Onc assay and will assess the efficacy of HER2-targeted therapy in patients with HER2-negative breast cancer who have been identified as having HER2 overexpression/activation by the PRO Onc Assay.
Inclusion criteria
- Breast Cancer